Obagi Medical Products, Inc. (OMPI) Misses Q1 EPS by 5c

Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q1 EPS of $0.16, $0.05 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $28.14 million.

Obagi Medical Products, Inc. reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Pan American Silver (PAAS) Misses Q2 EPS by 19c
• Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c